Valuation: Compumedics Limited

Market Cap 54.93M 39.4M 33.95M 32.14M 29.13M 54.66M 3.76B 382M 147M 1.91B 148M 145M 6.05B P/E 2026
255x
P/E 2027 * 10.7x
Enterprise Value 54.93M 39.4M 33.95M 32.14M 29.13M 54.66M 3.76B 382M 147M 1.91B 148M 145M 6.05B EV / Sales 2026
0.85x
EV / Sales 2027 * 0.73x
Free-Float
36.04%
Yield 2026 *
-
Yield 2027 * 8.89%
1 day+22.22%
1 week+10.00%
Current month+7.84%
1 month+22.22%
3 months+12.24%
6 months-5.17%
Current year-17.91%
1 week 0.22
Extreme 0.225
0.28
1 month 0.22
Extreme 0.215
0.28
Current year 0.22
Extreme 0.215
0.45
1 year 0.22
Extreme 0.215
0.45
3 years 0.15
Extreme 0.15
0.45
5 years 0.14
Extreme 0.135
0.45
10 years 0.14
Extreme 0.135
0.96
Manager TitleAgeSince
Chief Executive Officer 67 16/12/2010
Director of Finance/CFO 61 11/11/2009
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman 67 16/12/2010
Director/Board Member 61 01/01/2000
Director/Board Member - 27/10/2022
Change 5-day change 1-year change 3-year change Capi.($)
+22.22%+10.00%-3.51%+48.65% 32.24M
+1.10%-0.65%+27.19%+19.36% 225B
-0.19%-3.62%+5.31%-20.72% 141B
+2.41%+0.67%-17.91%+21.95% 130B
-0.28%-10.08%-58.15%-19.21% 62.29B
+2.50%+1.40%-18.09%-13.55% 49.39B
-2.77%-6.15%+8.77%+15.31% 48.63B
+2.66%-2.61%+19.22%+29.53% 41.42B
+1.67%-0.25%+38.24%+52.80% 40.12B
-0.60%-4.41%-19.20%+49.15% 31.23B
Average +2.91%-3.91%-1.81%+18.33% 76.97B
Weighted average by Cap. +0.75%-2.40%+2.84%+10.48%

Financials

2026 2027 *
Net sales 60.3M 43.25M 37.26M 35.28M 31.98M 60M 4.13B 419M 161M 2.1B 162M 159M 6.64B 75.6M 54.22M 46.72M 44.23M 40.09M 75.22M 5.18B 525M 202M 2.64B 204M 199M 8.33B
Net income 2.3M 1.65M 1.42M 1.35M 1.22M 2.29M 158M 15.98M 6.15M 80.18M 6.2M 6.06M 253M 6M 4.3M 3.71M 3.51M 3.18M 5.97M 411M 41.7M 16.03M 209M 16.16M 15.81M 661M
Net Debt - -
Logo Compumedics Limited
Compumedics Limited is an Australia-based medical device company which is involved in the development, manufacture, and commercialization of diagnostics technology for sleep, brain and ultrasonic blood flow monitoring applications. Its geographic segments include the Americas, Australia and Asia Pacific, and Europe and the Middle East. It sells all of its product offerings in this region, including sleep diagnostic systems, clinical electroencephalograms (EEG systems), brain monitoring systems, ultrasonic blood-flow systems, supplies and technical service and support. It provides Sleep Diagnostics and Neurology Diagnostics Solutions. Its products include Compumedics Siesta, Compumedics Somfit, Compumedics Somte PSG and others. It provides a range of solutions for the neurology laboratory, from clinical epilepsy monitoring applications to Transcranial Doppler Sonography. Its other products include Grael 4K PSG, Falcon HST, Okti, Neuvo 64-512 Channel LTM EEG and others.
Employees
175
Date Price Change Volume
14/09/26 A$0.2750 +22.22% 67,296
11/09/26 A$0.2250 -2.17% 80,604
10/09/26 A$0.2300 -1.08% 90,333
09/09/26 A$0.2325 -3.12% 124,099
08/09/26 A$0.2400 -4.00% 2,000
Trader
-
Investor
-
Global
-
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.2250AUD
Average target price
0.6500AUD
Spread / Average Target
+188.89%

Annual profits - Rate of surprise

40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!